FMP
RavenQuest BioMed Inc.
RVVQF
PNK
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.
0.00001 USD
0 (0%)
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
-
-
-
81.36k
910.09k
1.14M
1.42M
1.78M
2.22M
2.78M
-
-
-
-
1.02k
25
25
25
25
-45.14k
-55.1k
-58.99k
-464.43k
-11.08M
227.52k
284.4k
355.51k
444.38k
555.48k
100
100
100
-570.82
-1.22k
20
20
20
20
-63.25k
-59.88k
-75.51k
-464.64k
-12.44M
227.52k
284.4k
355.51k
444.38k
555.48k
100
100
100
-571.08
-1.37k
20
20
20
20
18.1k
4.78k
16.52k
207.11
1.36M
910.67k
1.14M
1.42M
1.78M
2.22M
100
100
100
0.25
149.71
80.05
80.05
80.05
80.05
EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income) EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company (1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments), (2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill) (3*) collections of assets (by ignoring depreciation of assets) (4*) different takeover histories (by ignoring amortization often stemming from goodwill)